Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May:124:108221.
doi: 10.1016/j.jsat.2020.108221. Epub 2020 Dec 3.

Depot buprenorphine during COVID-19 in Australia: Opportunities and challenges

Shalini Arunogiri  1 , Nicholas Lintzeris  2
Affiliations

Depot buprenorphine during COVID-19 in Australia: Opportunities and challenges

Shalini Arunogiri et al. J Subst Abuse Treat. 2021 May.

Abstract

The COVID-19 pandemic has presented challenges for traditional models of opioid use disorder treatment worldwide. Depot buprenorphine became available in Australia shortly before the height of the COVID-19 pandemic. This timing provided us an opportunity to examine the utilization and uptake of depot buprenorphine, and to understand the particular benefits and implementation challenges associated with this new formulation of opioid agonist treatment.

Keywords: Buprenorphine; Opioid; Opioid use disorder.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Depot buprenorphine utilization across selected New South Wales government-sector treatment services (Data source: reports from local services of number of clients in depot treatment on 1st of each month).
See this image and copyright information in PMC

References

    1. Alexander G.C., Stoller K.B., Haffajee R.L., Saloner B. 2020. An epidemic in the midst of a pandemic: Opioid use disorder and COVID-19. American College of Physicians. - PMC - PubMed
    1. Dunlop A., Lokuge B., Masters D., Sequeira M., Saul P., Dunlop G.…Haber P. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduction Journal. 2020;17:1–7. - PMC - PubMed
    1. Dunlop A.J., White B., Roberts J., Haber P.S., Oldmeadow C., Searles A., et al. Introduction of long‐acting depot buprenorphine in prison—the UNLOC‐T study. College of Problems on Drug Dependence (CPDD) 2020:22–24. Virtual Scientific Meeting.
    1. Frost M., Bailey G.L., Lintzeris N., Strang J., Dunlop A., Nunes E.V.…Haber P. Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder. Addiction. 2019;114(8):1416–1426. - PMC - PubMed
    1. Gowing L., Ali R., Dunlop A., Farrell M., Lintzeris N. Department of Health; Canberra: 2014. National guidelines for medication-assisted treatment of opioid dependence.

MeSH terms